Evolution of pulmonary inflammation and nutritional status in infants and young children with cystic fibrosis

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Thorax

• Publication date

  2011-03-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/thx.2010.139493PMID 21398685
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ethics approval This study was conducted with the approval of the East London and City Health Authority Ethic Committee. Provenance and peer review Not commissioned; externally peer reviewed.

  2011cited by this paper
• Cystic Fibrosis

  2009cited by this paper
• Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening.

  2009cited by this paper
• Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening.

  2009cited by this paper
• Recovery of Birth Weight z Score Within 2 Years of Diagnosis Is Positively Associated With Pulmonary Status at 6 Years of Age in Children With Cystic Fibrosis

  2009cited by this paper
• Improvements in lung function outcomes in children with cystic fibrosis are associated with better nutrition, fewer chronic pseudomonas aeruginosa infections, and dornase alfa use.

  2008cited by this paper
• Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis

  2008cited by this paper
• Lung function in infants with cystic fibrosis diagnosed by newborn screening.

  2008cited by this paper
• Evaluation of body mass index percentiles for assessment of malnutrition in children with cystic fibrosis

  2007cited by this paper
• Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction.

  2007cited by this paper
• Cystic fibrosis mortality and survival in the UK: 1947–2003

  2007cited by this paper
• Classification of nutritional status in cystic fibrosis

  2006cited by this paper
• Correlation of forced oscillation technique in preschool children with cystic fibrosis with pulmonary inflammation

  2005cited by this paper
• Lower Airway Inflammation in Infants with Cystic Fibrosis Detected by Newborn Screening

  2005cited by this paper
• Diagnosis of cystic fibrosis after newborn screening: The Australasian experience—twenty years and five million babies later: A consensus statement from the Australasian paediatric respiratory group

  2005cited by this paper
• Prophylactic antibiotics for cystic fibrosis.

  2003cited by this paper
• British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood.

  1998cited by this paper
• Lower airway inflammation in infants and young children with cystic fibrosis.

  1997cited by this paper
• Early pulmonary inflammation in infants with cystic fibrosis.

  1995cited by this paper
• A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto.

  1988cited by this paper

• Lung function outcomes of cystic fibrosis patients after early-life pulmonary exacerbations: National registry analysis.

  2026cites this paper
• Adherence to Anti‐Staphylococcal Prophylaxis in the First Two Years of Life and Microbiological Outcomes in the First Six Years of Life in Children With Cystic Fibrosis

  2025cites this paper
• Cooling the flames, clearing the airways: systemic inflammation in the era of elexacaftor/tezacaftor/ivacaftor

  2025cites this paper
• Protease-activated receptor 1 in the pathogenesis of cystic fibrosis

  2025cites this paper
• Update on advances in cystic fibrosis towards a cure and implications for primary care clinicians.

  2024cites this paper
• Factors associated with pulmonary function decline of patients in the cystic fibrosis registry of Turkey: A retrospective cohort study

  2024cites this paper
• The effect of Lactobacillus reuteri on pulmonary function test and growth of cystic fibrosis patients.

  2024cites this paper
• Ethnic differences in staphylococcus aureus acquisition in cystic fibrosis

  2023cites this paper
• The association of the advanced lung cancer inflammation index with postoperative complications in patients undergoing lung resection for bronchiectasis

  2023cites this paper
• Nasal airway inflammatory responses and pathogen detection in infants with cystic fibrosis.

  2023cites this paper
• Advanced pulmonary drug delivery formulations for the treatment of cystic fibrosis.

  2023cites this paper
• Neutrophil lymphocyte ratio, mean platelet volume, and immunoreactive trypsinogen as early inflammatory biomarkers for cystic fibrosis in infancy: A retrospective cohort study

  2023cites this paper
• Cystic Fibrosis Reprograms Airway Epithelial IL-33 Release and Licenses IL-33 Dependent Inflammation.

  2023cites this paper
• Association between early chronic methicillin‐susceptible Staphylococcus aureus colonization and lung function in children with cystic fibrosis

  2022cites this paper
• Factors in childhood associated with lung function decline to adolescence in cystic fibrosis.

  2022cites this paper
• Essential Fatty Acid Deficiency in Cystic Fibrosis Disease Progression: Role of Genotype and Sex

  2022cites this paper
• Editorial overview - 2022 respiratory issue: Cystic fibrosis pathophysiology, models, and novel therapies.

  2022cites this paper
• CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis

  2022cites this paper
• DNA Methylation at ATP11A cg11702988 Is a Biomarker of Lung Disease Severity in Cystic Fibrosis: A Longitudinal Study

  2021cites this paper
• UPR modulation of host immunity by Pseudomonas aeruginosa in cystic fibrosis

  2021cites this paper
• Impact of Airway Inflammation on the Efficacy of CFTR Modulators

  2021cites this paper
• The Interplay between the Unfolded Protein Response, Inflammation and Infection in Cystic Fibrosis

  2021cites this paper
• TMEM16A/ANO1: Current Strategies and Novel Drug Approaches for Cystic Fibrosis

  2021cites this paper
• Being Underweight Increases the Risk of Non-Cystic Fibrosis Bronchiectasis in the Young Population: A Nationwide Population-Based Study

  2021cites this paper
• IRE1α Is a Therapeutic Target for Cystic Fibrosis Airway Inflammation

  2021cites this paper
• Early Cystic Fibrosis Lung Disease

  2020cites this paper
• Cystic Fibrosis with Pancreatic Insufficiency: A Case Report

  2020cites this paper
• Treatment of pulmonary exacerbations in cystic fibrosis

  2020cites this paper
• Airway Inflammation and Host Responses in the Era of CFTR Modulators

  2020cites this paper
• Impact at school age of early chronic methicillin‐sensitive Staphylococcus aureus infection in children with cystic fibrosis

  2020cites this paper
• UPR modulation of host immunity by P. aeruginosa in cystic fibrosis.

  2020cites this paper
• The impact of CFTR modulator therapies on CF airway microbiology.

  2020cites this paper
• The role of geographical location and climate on recurrent Pseudomonas infection in young children with Cystic Fibrosis.

  2019cites this paper
• Higher Interleukin-7 serum concentrations in patients with cystic fibrosis correlate with impaired lung function.

  2019cites this paper
• Developmental Milestones in Pediatric Research: A Case for Including Efficacy as Part of Interventional Trials in Infants with Cystic Fibrosis

  2019cites this paper
• Pulmonary findings in infants with cystic fibrosis during the first year of life: Results from the Baby Observational and Nutrition Study (BONUS) cohort study

  2019cites this paper
• Aerosolized Bovine Lactoferrin Counteracts Infection, Inflammation and Iron Dysbalance in A Cystic Fibrosis Mouse Model of Pseudomonas aeruginosa Chronic Lung Infection

  2019cites this paper
• Predicting disease progression in cystic fibrosis

  2018cites this paper
• ASSOCIATION OF NUTRITIONAL STATUS WITH LUNG FUNCTION AND MORBIDITY IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS: A 36-MONTH COHORT STUDY

  2018cites this paper
• TGFβ as a therapeutic target in cystic fibrosis

  2018cites this paper
• Human Cellular Models for the Investigation of Lung Inflammation and Mucus Production in Cystic Fibrosis

  2018cites this paper
• Aspectos microbiológicos del microbioma broncopulmonar y descripción clínica y demográfica de los pacientes con fibrosis quística: estudio multicéntrico en españa

  2018cites this paper
• Is there a role for inhaled anti-inflammatory drugs in cystic fibrosis treatment?

  2018cites this paper
• The role of neonatal screening in nutritional evolution in the first 12 months after diagnosis of cystic fibrosis.

  2018cites this paper
• Widespread airway distribution and short-term phenotypic correction of cystic fibrosis pigs following aerosol delivery of piggyBac/adenovirus

  2018cites this paper
• Adaptation of commensal proliferating Escherichia coli to the intestinal tract of young children with cystic fibrosis

  2018cites this paper
• Role of IRE1α/XBP-1 in Cystic Fibrosis Airway Inflammation

  2017cites this paper
• Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It?

  2017cites this paper
• The association between Staphylococcus aureus and subsequent bronchiectasis in children with cystic fibrosis.

  2017cites this paper
• CFTR Involvement in Cell Migration and Epithelial Restitution

  2017cites this paper
• Factors associated with malnutrition in adolescent and adult patients with cystic fibrosis.

  2017cites this paper
• Lack of small colony variants of Staphylococcus aureus from lower respiratory tract specimens

  2017cites this paper
• Effects of Diagnosis by Newborn Screening for Cystic Fibrosis on Weight and Length in the First Year of Life

  2017cites this paper
• IL-22 exacerbates weight loss in a murine model of chronic pulmonary Pseudomonas aeruginosa infection

  2016cites this paper
• The dual phosphodiesterase 3 and 4 inhibitor RPL554 stimulates CFTR and ciliary beating in primary cultures of bronchial epithelia.

  2016cites this paper
• Forrester, Doug L. and Knox, Alan J. and Smyth, Alan R. and Fogarty, Andrew W. (2013) Measures of body habitus are associated with lung function in adults with cystic fibrosis: a population-based study

  2016cites this paper
• Respiratory infection rates differ between geographically distant paediatric cystic fibrosis cohorts

  2016cites this paper
• Neutrophil plasticity enables the development of pathological microenvironments: implications for cystic fibrosis airway disease

  2016cites this paper
• Diagnosis and early life risk factors for bronchiectasis in cystic fibrosis: a review

  2016cites this paper
• Background and Epidemiology.

  2016cites this paper
• A murine model of early Pseudomonas aeruginosa lung disease with transition to chronic infection

  2016cites this paper
• Clinical features of childhood primary ciliary dyskinesia by genotype and ultrastructural phenotype.

  2015cites this paper
• The human microbiome: opportunities and challenges for clinical care

  2015cites this paper
• Antibacterial and Biophysical Characterization of Nitric Oxide-Releasing Chitosan Oligosaccharides – Towards a New Cystic Fibrosis Therapeutic

  2015cites this paper
• Changes in Pulmonary Function and Controlled Ventilation-High Resolution CT of Chest After Antibiotic Therapy in Infants and Young Children with Cystic Fibrosis

  2015cites this paper
• Neonatal Screening and Nutrition/Growth in Cystic Fibrosis: A Review

  2015cites this paper
• Dépistage néonatal et prise en charge précoce de la mucoviscidose

  2015cites this paper
• II. Topic Sessions

  2015cites this paper
• Evolution of cystic fibrosis lung function in the early years

  2015cites this paper
• The Evolution of Cystic Fibrosis Care.

  2015cites this paper
• Lactoferrin and Cystic Fibrosis Airway Infection

  2015cites this paper
• Social network analysis of Pseudomonas aeruginosa in cystic fibrosis.

  2015cites this paper
• Factors impacting the growth and nutritional status of cystic fibrosis patients younger than 10 years of age who did not undergo neonatal screening

  2015cites this paper
• Early pulmonary inflammation and lung damage in children with cystic fibrosis

  2015cites this paper
• Social network analysis of Pseudomonas aeruginosa in cystic fi brosis

  2015cites this paper
• Biomarkers in Paediatric Cystic Fibrosis Lung Disease.

  2015cites this paper
• Detrimental effects of secondhand smoke exposure on infants with cystic fibrosis

  2015cites this paper
• Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs.

  2015cites this paper
• Symposium Session Summaries

  2014cites this paper
• Molecular mechanisms of enhanced expression of the chemokine interleukin 8 (CXCL8) in cystic fibrosis (CF) airway epithelial cells

  2014cites this paper
• Airway, but not serum or urinary, levels of YKL-40 reflect inflammation in early cystic fibrosis lung disease

  2014cites this paper
• Lactoferrin differently modulates the inflammatory response in epithelial models mimicking human inflammatory and infectious diseases

  2014cites this paper
• Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study.

  2014cites this paper
• Predictors and outcome of low initial forced expiratory volume in 1 second measurement in children with cystic fibrosis.

  2014cites this paper
• Cystic fibrosis patients assisted by a program nutrition therapy: assessment of the use of supplements in patients colonized and non colonized by P. aeruginosa.

  2014cites this paper
• Lactobacillus reuteri ATCC55730 in Cystic Fibrosis

  2014cites this paper
• Defective Innate Immunity and Hyper-Inflammation in Newborn CFTR-Knockout Ferret Lungs.

  2014cites this paper
• Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children.

  2014cites this paper
• Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications

  2013cites this paper
• Lactobacillus reuteri ATCC 55730 in Cystic Fibrosis

  2013cites this paper
• Pathophysiology of cystic fibrosis and drugs used in associated digestive tract diseases.

  2013cites this paper
• A cohort study of the Copenhagen CF Centre eradication strategy against Staphylococcus aureus in patients with CF.

  2013cites this paper
• Recurrent lower respiratory tract infections in children: a practical approach to diagnosis.

  2013influential citation
• Expression and regulation of interferon-related development regulator-1 in cystic fibrosis neutrophils.

  2013cites this paper
• Risk factors for bronchiectasis in children with cystic fibrosis.

  2013cites this paper
• Clinimetric properties of bronchoalveolar lavage inflammatory markers in cystic fibrosis

  2013cites this paper
• Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis.

  2013cites this paper
• Bacterial Respiratory Pathogens in Children With Inherited Immune and Airway Disorders: Nasopharyngeal Carriage and Disease Risk

  2013cites this paper
• Staphylococcus aureus in early cystic fibrosis lung disease

  2013cites this paper
• Cystic fibrosis therapeutics: the road ahead.

  2013cites this paper